What You Should Know
- Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
- Moving beyond the "AI promise" gap, the company provides end-to-end AI systems that plug directly into existing drug development workflows, already serving over a dozen pharmaceutical and biotech customers to optimize target discovery and protein manufacturing.
The Systemic Pivot: Bridging the Gap Between Promise and Reality
While
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Xella Health Raises $3.7M to Pioneer AI-Powered Menstrual Fluid Diagnostics
What You Should Know
- Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for "decoding" female biology.
- Led by Precursor Ventures, the company is pioneering a first-of-its-kind diagnostic platform that combines menstrual fluid analysis with peripheral blood and AI-powered multi-omics to identify the root causes of chronic conditions like endometriosis, PCOS, and perimenopause.
The Biological Signal: Tapping Into Menstrual
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI
What You Should Know
- Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
- Unlike traditional AI that focuses on discovering new molecules, Allos targets the "formulation gap"—applying causal modeling to existing complex generics and next-generation medicines to improve their tolerability, bioavailability, and long-term patient outcomes.
The Problem: The
Read More
Pomelo Care Secures $92M to Scale Virtual Maternity Model Across Women’s Health
What You Should Know
- Pomelo Care has closed a $92 million Series C funding round, propelling the company to a $1.7B valuation.
- After proving its virtual model can reduce preterm births by 37% and emergency room visits by 46%, Pomelo is moving beyond its maternity roots to launch comprehensive pediatric and midlife care programs, now covering more than 25 million lives nationwide.
The Accountability Pivot: Evidence Over Hype
In a 2026 market where "Agentic AI" and "Digital
Read More
The Automated OR: Apella Secures $80M to Scale Ambient Video Intelligence Across the Surgical Suite
What You Should Know
- Apella has announced an $80M Series B round to scale its ambient AI platform designed for the most complex environment in the hospital: the operating room (OR). The round was led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners, and includes new investors K2 HealthVentures, OpAmp Capital, and Houston Methodist.
- By using computer vision to autonomously identify 14 surgical
Read More
Canopy Secures $22M to Scale Healthcare Safety Platform
What You Should Know
- Canopy, the category leader in connected safety platforms, has closed a $22M Series B funding round led by 111° West Capital and ACME Capital.
- As workplace violence in healthcare has surged 63% over the last five years, Canopy has rapidly scaled its "Location ID" network to protect over 300,000 healthcare workers across 60 major U.S. systems, providing a unified infrastructure for both staff safety and operational intelligence.
The Safety-First Pivot:
Read More
Topos Bio Emerges from Stealth to Tackle Disordered Proteins with $10.5M and Frontier AI
What You Should Know
- Topos Bio has emerged from stealth with $10.5M in seed funding to solve one of the most persistent challenges in medicine: targeting intrinsically disordered proteins (IDPs). The seed funding was led by Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao (CEO of Unconventional AI).
- While traditional models like AlphaFold focus on static structures, Topos Bio’s foundation model,
Read More
Carna Health Raises $8M to Scale Global AI-Driven Kidney Screening
What You Should Know
- Carna Health has raised $8M to scale its AI-driven Cardio-Kidney-Metabolic (CKM) platform. The round included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi.
- Following a successful initiative in Cameroon that screened 35,000 individuals, Carna is expanding its partnership with Siemens Healthineers to bring
Read More
Oasys Raises $4.6M to Build the First AI-Native OS for Behavioral Health
What You Should Know:
- Oasys Health ("Oasys"), the first AI-native operating system for behavioral health, today announces $4.6M in funding, including a $4M seed round led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, and $600K in pre-seed funding from 1984 Ventures.
- As demand for mental health support surges, Oasys will use new capital to enhance its AI-powered platform, deepen integrations with leading wearables and health apps, grow its
Read More
